The Ledger

11 candidates in trigger band, 0 entered, 11 skipped. Exits: 0.

• TSLAskipv1

  There are no recent headlines or catalysts explaining the ~3.5% decline in TSLA today, making it difficult to assess whether this is a fundamental move or noise/technical selling. The macro context (elevated 5-year inflation expectations) is not directly bearish for TSLA specifically. With only 60 minutes remaining until the forced close, there is limited time for a meaningful continuation, and without a clear catalyst, mean-reversion or stabilization into the close is equally plausible.

• CRMskipv1

  There are no recent headlines or clear catalysts explaining the -3.28% decline in CRM today, making it difficult to assess whether this is a fundamental move or noise/sector rotation. The macro context (elevated 5Y inflation expectations) is more relevant to commodity-linked sectors than enterprise software, offering no directional signal for CRM. With only 60 minutes remaining and no identifiable catalyst, the probability of meaningful continuation is limited and the setup does not meet the threshold for a high-conviction trade.

• KOskipv1

  KO has moved up 2.03% with no identifiable news catalyst to explain the move, suggesting this may be a gap or broader market-driven lift rather than a stock-specific driver. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is not particularly favorable for a consumer staples/defensive name like KO as it implies rate pressure. With only 60 minutes remaining, there is limited runway for meaningful continuation, and without a clear fundamental catalyst the probability of sustained buying into the close is below threshold.

• LLYskipv1

  LLY has moved up 2.54% today with no accompanying news catalysts or earnings events visible in the headlines, making it difficult to attribute the move to a durable fundamental driver. The macro context around elevated inflation expectations (T5YIE at 1.9σ above trend) is more relevant to Gold, Energy, and TIPS sectors, not large-cap pharma, providing no tailwind support. With only 60 minutes remaining until the forced close, there is limited time for meaningful continuation, and without a clear catalyst the move risks fading or consolidating into the close.

• ORCLskipv1

  There are no recent headlines or clear fundamental catalysts to explain the -4.56% move in ORCL today, making it difficult to assess whether selling pressure has a narrative driver that would sustain it into the close. The macro context (elevated 5-year inflation expectations) is not directly bearish for a large-cap tech/software name like Oracle. With only 60 minutes remaining and no identifiable catalyst, the move may reflect morning institutional selling or thin liquidity rather than a sustained trend, suggesting limited additional downside conviction.

• ABBVskipv1

  ABBV has moved up 2.84% with no identifiable news catalyst in the headlines, suggesting the move may be driven by sector rotation, options activity, or thin volume rather than a fundamental event. The macro context (elevated 5Y inflation expectations) is not directly supportive of a healthcare/pharma name like ABBV. With only 60 minutes remaining until the forced close, there is limited time for meaningful continuation, and without a clear catalyst, mean reversion or consolidation is equally plausible.

• AMDskipv1

  AMD is down 4% but the macro news environment is broadly constructive for AI/chip names — Wedbush's positive AI demand commentary and Intel's massive intraday gain suggest sector sentiment is not uniformly negative, creating reversal risk. The drop may reflect a gap or early-session pressure rather than a sustained catalyst specific to AMD, as no AMD-specific negative news appears in the headlines. With only 60 minutes remaining until the forced close, there is limited time for the move to extend meaningfully, and mean-reversion into the close is common in the absence of a clear ticker-specific catalyst.

• NFLXskipv1

  There are no recent headlines or identifiable catalysts explaining the 2.28% move in NFLX, making it difficult to assess whether this is driven by sustained buying interest or a thin-volume spike. The macro context (elevated 5-year inflation expectations) is not particularly constructive for a growth/technology name like Netflix, as higher real rates tend to pressure high-multiple equities. With only 60 minutes remaining until the forced close, there is limited runway for meaningful continuation even if the setup were more compelling.

• UNHskipv1

  UNH has moved up 3.12% with no identifiable catalyst from recent headlines, suggesting this may be a gap or thin-volume spike rather than a news-driven continuation move. The macro context (elevated inflation expectations via T5YIE) is not directly supportive of healthcare sector upside. With only 60 minutes remaining until the forced close, there is limited runway even if momentum were present, and mean-reversion risk in a no-news environment is elevated.

• COSTskipv1

  COST has moved up ~2.1% with no identifiable catalyst from recent headlines, suggesting the move may be gap-related or driven by broader market sentiment rather than a specific fundamental driver. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is not directly a tailwind for a consumer staples/warehouse retailer like Costco and could even pressure margins. With only 60 minutes remaining until the forced close, there is limited runway for meaningful continuation, and without a clear catalyst the risk of mean reversion or consolidation is elevated.

• AVGOskipv1

  There are no recent headlines or clear catalysts to explain the -3.19% move in AVGO today, making it difficult to assess whether this is a sustained selling episode or a gap-down that may partially recover. The macro context (elevated 5Y inflation expectations) is not directly bearish for semiconductor names like AVGO. With only 60 minutes remaining and no identifiable catalyst supporting continuation, the risk/reward for a directional bet is unfavorable.

10 candidates in trigger band, 0 entered, 10 skipped. Exits: 0.

• COSTskipv1

  COST is up ~2% with 74 minutes remaining but there are no recent headlines or identifiable catalysts driving the move, making it difficult to assess whether this reflects fundamental buying or noise. The macro context (elevated 5-year inflation expectations at 1.9σ above trend) is not a direct tailwind for consumer staples/warehouse retail like Costco. Without a clear catalyst and given that a 2% intraday move in a large-cap like COST without news often reverts partially into the close, continuation is uncertain.

• ABBVskipv1

  ABBV has moved up 3.16% today with no identifiable headline catalyst in the last 24 hours, making it difficult to assess whether this move has fundamental support or is driven by technical flows or sector rotation. The macro context flags elevated inflation expectations (T5YIE at 1.9σ above trend), which is not a clear tailwind for healthcare/pharma names like ABBV. With 74 minutes remaining, there is insufficient catalyst clarity to confidently expect continuation, and large gap-up moves without news often see partial mean reversion into the close.

• NFLXskipv1

  There are no recent headlines or identifiable catalysts to explain the 2.31% intraday move in NFLX, making it difficult to assess whether the move is driven by fundamental news or is simply noise/thin-volume drift. The macro context (elevated 5-year inflation expectations) is not a direct tailwind for growth/tech names like NFLX and could even be a mild headwind. With 74 minutes remaining and no clear catalyst supporting continuation, the move has a reasonable chance of mean-reverting or stalling into the close.

• AVGOskipv1

  There are no recent headlines or clear catalysts explaining the -3.05% move in AVGO today, making it difficult to assess whether this is a fundamental shift or a technical/macro-driven dip. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is a broader headwind for growth/tech names like AVGO but is not a direct catalyst. With 74 minutes remaining, there is limited time for further meaningful downside continuation without a fresh catalyst, and mean-reversion pressure is plausible in the absence of news-driven selling.

• AMDskipv1

  AMD is down ~4% today, but the macro backdrop from recent headlines is constructive for AI chip demand, with Wedbush reinforcing AI strength across chips and cloud — this could provide buying pressure into the close and limit further downside. The elevated 5-year inflation breakeven (1.9σ above trend) adds some macro uncertainty, but is not a direct chip sector headwind. With 74 minutes remaining, there is meaningful time for a partial recovery, and the lack of a clear company-specific negative catalyst suggests the move may be overdone rather than a sustained directional trend.

• TSLAskipv1

  There are no recent headlines or clear fundamental catalysts to explain the -3.43% decline in TSLA today, making it difficult to assess whether this is a sustained move or a mean-reversion opportunity. The macro context around elevated inflation expectations (T5YIE at 1.9σ above trend) is not directly negative for TSLA in the short term and does not provide a strong directional signal. With 74 minutes remaining and no identifiable catalyst, the probability of continuation versus reversal is roughly even, warranting an uncertain stance.

• UNHskipv1

  UNH has moved up 3.01% today but there are no supporting headlines or catalysts visible to explain the move, making it difficult to assess whether this is a fundamental re-rating or a technical/flow-driven spike. The macro context (elevated inflation expectations via T5YIE) is not directly supportive of managed care/healthcare insurers. With 74 minutes remaining, some mean reversion or consolidation is plausible absent a clear catalyst, so a high-confidence continuation call is not warranted.

• ORCLskipv1

  There are no recent headlines or identifiable catalysts explaining the ~4.5% decline in ORCL today, making it difficult to assess whether this is a fundamental driver or technical/flow-driven move. The macro context (elevated 5-year inflation expectations) is most relevant to commodities and TIPS, not directly to an enterprise software name like Oracle. With 74 minutes remaining and no clear news catalyst, mean-reversion pressure is plausible, but without understanding the source of the move, conviction in either direction is low.

• LLYskipv1

  LLY is up 2.42% with no identifiable news catalyst driving the move, making it difficult to assess whether momentum will sustain into the close. The macro context around elevated 5-year inflation expectations is not directly relevant to a large-cap pharma name like LLY. With 74 minutes remaining, there is some time for continuation, but absent a clear fundamental catalyst, the move could easily fade or consolidate near current levels.

• CRMskipv1

  There are no recent headlines or clear catalysts explaining CRM's ~2.92% decline today, making it difficult to assess whether selling pressure will persist into the close. The macro context (elevated 5-year inflation expectations) is more relevant to commodities and TIPS than to a software name like CRM, providing no directional edge. With 74 minutes remaining and no identifiable news-driven catalyst, the move could reflect broad market noise or sector rotation, and a partial mean-reversion into the close is equally plausible.

10 candidates in trigger band, 0 entered, 10 skipped. Exits: 0.

• ORCLskipv1

  There are no recent headlines or clear catalysts explaining the ~4.84% decline in ORCL, which makes it difficult to assess whether this is a fundamental move or noise/thin-volume selling. The macro context around elevated 5-year inflation expectations is more relevant to commodities and TIPS than to large-cap tech/software like ORCL. With 90 minutes remaining and no supporting narrative, mean-reversion is plausible, but without a clear catalyst for either continuation or reversal, the most prudent call is uncertain.

• AVGOskipv1

  There are no recent headlines or clear catalysts explaining the ~3.54% decline in AVGO today, making it difficult to determine whether this is a sustained directional move or a gap/spike that may partially reverse. The macro context (elevated 5-year inflation expectations) is not directly bearish for semiconductors like AVGO, offering no strong confirming signal for continuation. With 90 minutes remaining and no identifiable news driver, mean-reversion pressure is plausible, and the risk/reward for a continuation trade is unclear.

• UNHskipv1

  UNH is up 2.15% with no recent headlines to explain the catalyst, making it difficult to assess whether this move is driven by substantive news or is a thin-volume drift. The macro context (elevated 5-year inflation expectations) is not directly relevant to managed healthcare and provides no sector tailwind. With 90 minutes remaining, there is time for continuation but without a clear catalyst, mean reversion into the close is equally plausible, especially given UNH's recent broader volatility.

• AMDskipv1

  AMD is down ~4.71% but the macro headline environment is actually constructive for AI/chip names — Wedbush reinforced AI demand strength and Intel saw a massive move higher, suggesting sector rotation rather than broad chip weakness may be at play. The elevated 5-year inflation expectations (2.62, +1.9σ) are not a direct AMD catalyst and the positive sector backdrop creates meaningful mean-reversion pressure. With 90 minutes remaining and no clear company-specific negative catalyst visible in the headlines, the risk/reward for continuation is roughly balanced, leaning slightly toward recovery rather than further downside.

• NFLXskipv1

  There are no recent headlines or identifiable catalysts to explain the 2.22% move in NFLX today, making it difficult to assess whether this is a sustained trend or a low-volume intraday spike. The macro context (elevated 5-year inflation expectations) does not particularly favor consumer discretionary/streaming names and provides no directional tailwind. With 90 minutes remaining there is modest time for continuation, but without a clear fundamental driver the probability of sustained upside into the close is not compelling enough to warrant a high-confidence directional bet.

• COSTskipv1

  COST has moved up 2.08% today with no identifiable catalyst from recent headlines, making it difficult to assess whether this is a sustained move or a gap/spike with limited follow-through. The macro context (elevated 5-year inflation expectations) is not a direct tailwind for consumer staples/warehouse retail like Costco. With 90 minutes remaining, there is some time for continuation, but without a clear fundamental driver, mean reversion or consolidation near current levels is equally plausible.

• LLYskipv1

  LLY is up 2.41% with no identifiable catalyst from recent headlines to explain or sustain the move, making it difficult to assign directional conviction. The macro context (elevated inflation expectations via T5YIE) is not directly relevant to large-cap pharma and provides no sector tailwind. With 90 minutes remaining and no clear fundamental driver, the move may represent profit-taking risk or a gap-fill scenario rather than a sustained trend into the close.

• ABBVskipv1

  ABBV has moved up ~2.87% with no identifiable news catalyst in the last 24 hours, suggesting the move may be gap-driven or sector-rotation-related rather than fundamentally supported. The macro context (elevated 5-year inflation expectations) is not directly relevant to a large-cap pharma name like ABBV. With 90 minutes remaining and no clear continuation catalyst, mean reversion or consolidation near current levels is equally plausible as further upside.

• CRMskipv1

  There are no recent headlines or clear fundamental catalysts driving CRM's -2.78% decline today, making it difficult to assess whether the move reflects genuine selling pressure or noise. The macro context (elevated 5Y inflation expectations) is more relevant to commodities and TIPS sectors than enterprise software, providing no directional edge for CRM. With 90 minutes remaining and no catalyst to anchor a view, the move could easily mean-revert into the close, so conviction is low.

• TSLAskipv1

  There are no recent headlines or clear catalysts explaining the -3.66% intraday drop in TSLA, making it difficult to assess whether this is a sustained trend or a temporary dip. The macro context (elevated 5-year inflation expectations) is not directly bearish for TSLA and does not provide a strong directional signal. With 90 minutes remaining and no identifiable news driver, the move could mean-revert into the close as buyers step in at a discount, warranting an uncertain stance rather than a continuation bet.

Inverse rotator: 0 closes, 0 entries, 0 held after.

• SHlog

  Not triggered: 5d return -1.43%, MA20 $34.49, close $33.73

• VXXlog

  Not triggered: 5d return -1.43%, MA20 $28.83, close $28.30

• SQQQlog

  Not triggered: 5d return -8.59%, MA20 $51.65, close $44.41

Weinstein run: 0 closes, 2 entries. 10 candidates considered.

• BKNGlog

  Stage 4: close $160.22 < MA150 $190.71 (-16.0%), MA falling, 31.4% off 52w high, vol 0.07× avg

• DASHlog

  Stage 4: close $155.47 < MA150 $200.45 (-22.4%), MA falling, 45.5% off 52w high, vol 0.05× avg

• NFLXlog

  Stage 4: close $87.61 < MA150 $97.14 (-9.8%), MA falling, 34.7% off 52w high, vol 0.10× avg

• IDXXlog

  Stage 4: close $537.92 < MA150 $644.68 (-16.6%), MA falling, 30.1% off 52w high, vol 0.09× avg

• VRSKlog

  Stage 4: close $169.47 < MA150 $206.42 (-17.9%), MA falling, 47.5% off 52w high, vol 0.06× avg

• METAlog

  Stage 4: close $599.33 < MA150 $648.71 (-7.6%), MA falling, 24.7% off 52w high, vol 0.04× avg

• ADBElog

  Stage 4: close $241.63 < MA150 $295.76 (-18.3%), MA falling, 42.9% off 52w high, vol 0.02× avg

• CTSHlog

  Stage 4: close $48.09 < MA150 $70.19 (-31.5%), MA falling, 44.7% off 52w high, vol 0.05× avg

• GEHClog

  Stage 4: close $62.53 < MA150 $76.49 (-18.2%), MA falling, 30.3% off 52w high, vol 0.04× avg

• PYPLlog

  Stage 4: close $45.52 < MA150 $54.78 (-16.9%), MA falling, 42.7% off 52w high, vol 0.06× avg

• MELIlog

  Stage 4: close $1579.07 < MA150 $1967.90 (-19.8%), MA falling, 40.3% off 52w high, vol 0.17× avg

• CMCSAlog

  Stage 4: close $24.93 < MA150 $28.16 (-11.5%), MA falling, 27.5% off 52w high, vol 0.10× avg

1 trigger(s), 0 bought, 1 skipped, 0 analyze failures, 1 watch-listed. Exits: 0.

• NFLXskip-19.6% off 30d highp=0.38v1

  Netflix's Q1 2026 financials are robust — $10.5B revenue, $2.9B net income, and $9B cash on hand reflect a fundamentally strong business. However, the 19.6% drop from the 30-day high appears to carry meaningful idiosyncratic headwinds: a Texas lawsuit alleging illegal data collection on children is a material regulatory risk that could attract further state-level actions, and the broader macro environment (elevated 5Y inflation breakevens, weak QQQ/IWM today) is not supportive of a near-term technical recovery. The $87.61 price is well below recent highs with no clear near-term catalyst to reverse the slide.

0 exits, no candidates in trigger band.

• portfoliolog

  No universe names in the 2-5% intraday move band.

5 pressure candidate(s), 0 opened, 5 skipped. Exits: 0.

1 trigger(s), 0 bought, 1 skipped, 0 analyze failures, 1 watch-listed. Exits: 0.

• NFLXskip-19.6% off 30d highp=0.41v2

  Netflix's most recent 10-Q shows strong fundamentals: $10.5B in quarterly revenue, $2.89B net income, $2.79B operating cash flow, and $9B in cash — no signs of financial deterioration. However, the 19.6% drop from the 30-day high appears to carry idiosyncratic stress (Texas lawsuit over data/privacy practices, rising regulatory scrutiny, price hike concerns) on top of a risk-off macro backdrop where QQQ is down 1.73% and IWM down 1.59%, and elevated 5-year inflation breakevens (T5YIE at 1.9σ above trend) compress growth multiples. The combination of genuine legal headline risk and a broad tech sell-off makes a full rebound to $108.95 within 90 days uncertain.

1 trigger(s), 0 bought, 1 skipped, 0 analyze failures, 1 watch-listed. Exits: 0.

• NFLXskip-19.6% off 30d highp=0.41v1

  Netflix's most recent 10-Q shows strong fundamentals: $10.5B in quarterly revenue, $2.9B net income, and $9B in cash, with positive operating cash flow — no signs of financial deterioration. The 19.6% pullback appears driven by macro headwinds (elevated 5-year inflation expectations at 1.9σ above trend pressuring growth multiples) and headline noise from a Texas lawsuit over data practices, rather than a fundamental business breakdown. However, the Texas lawsuit introduces real legal/regulatory overhang, and the current price of $87.61 against a $108.95 30-day high implies a meaningful re-rating that may not fully reverse within 90 days given the macro environment.

Ratio 55.85, in-band. Holding GLD.

• portfoliohold

  Ratio 55.85 is inside [50, 80]; holding GLD.

Weinstein run: 0 closes, 0 entries. 0 candidates considered.

• portfoliolog

  Already at target 10 positions; no entries.

Weinstein run: 0 closes, 0 entries. 0 candidates considered.

• portfoliolog

  Already at target 10 positions; no entries.

10 candidates in trigger band, 0 entered, 10 skipped. Exits: 0.

• AMDskipv1

  The headline evidence is broadly constructive for AI/chip names (Wedbush noting strong AI demand), which creates a headwind against continued selling pressure on AMD specifically. The -4.83% decline lacks a clear negative catalyst in the recent headlines, suggesting this may be symptomatic of broader sector rotation or profit-taking rather than a sustained directional move. With 105 minutes remaining and a macro backdrop that is mildly inflationary (elevated 5Y breakevens) but not outright bearish for semis, a mean-reversion bounce into the close is at least as likely as continuation of the selloff.

• ABBVskipv1

  ABBV is up 3.19% with no identifiable news catalyst or earnings event driving the move, making it difficult to assess whether this is a sustainable directional trend or a gap/spike that may fade. The macro context (elevated 5-year inflation expectations) is not directly relevant to ABBV as a healthcare/pharma name. With 105 minutes remaining and no clear fundamental catalyst, mean-reversion pressure after a ~3% intraday move is a real risk, and the lack of headlines leaves the driver ambiguous.

• LLYskipv1

  LLY is up 2.60% with no recent headlines to explain the catalyst, making it difficult to assess whether this move has fundamental support or is noise/technical in nature. The macro context (elevated 5Y inflation expectations) is not directly relevant to a large-cap pharmaceutical like LLY, offering no sector tailwind. With 105 minutes remaining and no clear news-driven catalyst, the probability of sustained continuation into the close is roughly coin-flip, and a cautious uncertain stance is warranted.

• NFLXskipv1

  NFLX is up 2.79% with no recent headline catalyst visible, suggesting the move may be driven by broader market momentum or sector rotation rather than a company-specific event. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is not a direct tailwind for growth/tech names like NFLX and could create headwinds. With 105 minutes remaining and no clear fundamental catalyst to anchor the move, mean reversion or consolidation is as likely as continuation.

• CRMskipv1

  There are no recent headlines or clear fundamental catalysts driving the -2.72% move in CRM today, making it difficult to assess whether selling pressure has a thesis behind it or is noise/broad market sympathy. The macro context (elevated 5Y breakeven inflation) is more relevant to commodities and TIPS than enterprise software, providing no direct headwind or tailwind signal for CRM. With 105 minutes remaining, mean-reversion is plausible in the absence of a clear catalyst, so continuation is not favored with high confidence.

• WMTskipv1

  The 2.06% move in WMT lacks a clear intraday catalyst visible in the headlines; the only recent coverage questions whether WMT is overvalued after strong gains, which is a mild headwind to further buying pressure. With 105 minutes remaining there is time for continuation, but elevated inflation expectations (T5YIE at 1.9σ above trend) could pressure consumer discretionary/staples sentiment and invite profit-taking in a name that has already run. Without a fresh fundamental catalyst such as an earnings beat or analyst upgrade, the move looks more like a gap or sector drift than a high-conviction continuation setup.

• AVGOskipv1

  There are no recent headlines or clear catalysts to explain the ~3.74% decline in AVGO today, making it difficult to assess whether this is a fundamental driver or a sympathy move with broader market dynamics. The macro context (elevated 5-year inflation expectations) is not directly bearish for semiconductors like AVGO, and without news-driven conviction, mean reversion into the close is plausible. With 105 minutes remaining and no identifiable catalyst, the move could partially retrace, warranting an uncertain stance rather than a continuation bet.

• TSLAskipv1

  There is no clear fundamental catalyst in the recent headlines explaining today's -4.01% decline in TSLA beyond general market activity, making it difficult to assign high conviction to continuation. The macro context highlights elevated inflation expectations (T5YIE at 2.62, 1.9σ above trend), which is more directly reactive to Gold/Energy/TIPS sectors than to TSLA specifically. With 105 minutes remaining, there is meaningful time for either a bounce or further selling, but absent a clear news-driven catalyst, mean reversion intraday is equally plausible, warranting an uncertain stance.

• ORCLskipv1

  There are no recent headlines or clear catalysts explaining the ~4.85% decline in ORCL today, making it difficult to assess whether selling pressure is fundamentally driven or represents a gap/flush that may stabilize. The macro context (elevated 5-year inflation expectations) is not directly bearish for a large-cap tech/cloud name like Oracle in the near term. With 105 minutes remaining, there is meaningful time for either a partial recovery or continued drift, but without a clear catalyst the setup does not meet the threshold for a high-conviction continuation trade.

• COSTskipv1

  COST is up ~2.08% with no identifiable news catalyst in the last 24 hours, making it difficult to attribute the move to a specific fundamental driver that would support continuation. The macro context (elevated 5-year inflation expectations at 1.9σ above trend) is not a direct tailwind for a consumer staples/warehouse retailer like Costco. With 105 minutes remaining and no clear catalyst, the move looks more like a gap or broad-market lift than a conviction-driven rally, suggesting mean-reversion or consolidation is as likely as continuation.

10 candidates in trigger band, 0 entered, 10 skipped. Exits: 0.

• WMTskipv1

  The 2.47% move in WMT lacks a clear intraday catalyst — the only recent headline questions whether the stock is overvalued after recent gains, which is a mildly bearish narrative that could cap further upside. With 135 minutes remaining there is time for movement, but absent a strong fundamental catalyst like earnings or a sector tailwind, large gap-up moves in defensive consumer staples names like WMT tend to consolidate or fade intraday rather than continue. The elevated inflation expectations (T5YIE at 1.9σ above trend) are not a direct tailwind for WMT and could weigh on consumer discretionary sentiment, adding further uncertainty to continuation.

• TSLAskipv1

  The -4.15% drop lacks a clear negative catalyst in recent headlines; in fact, the Musk/Cook/Trump/Xi summit news is potentially a mild positive for TSLA given trade-war de-escalation implications for supply chains. Elevated 5Y inflation expectations (2.62, +1.9σ) create a macro headwind for growth stocks like TSLA, but this is not a fresh catalyst specific to today. With 135 minutes remaining, there is enough time for a partial mean-reversion bounce off the intraday lows rather than further continuation lower.

• COSTskipv1

  COST is up 2.30% with no visible news catalyst driving the move, making it difficult to assess whether this is fundamental buying or a gap that may fade. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is not a direct tailwind for a consumer staples/warehouse retailer like Costco and could weigh on discretionary spending sentiment. With 135 minutes remaining and no confirming catalyst, the risk of mean reversion is meaningful, warranting an uncertain stance.

• UNHskipv1

  UNH is up 2.61% with no identifiable news catalyst in the headlines, suggesting the move may be a gap or algorithmic/sector rotation trade rather than a fundamentally driven continuation. The macro context (elevated 5-year inflation expectations) is not a direct tailwind for managed healthcare names and provides no supporting narrative. With 135 minutes remaining there is time for continuation, but without a clear catalyst and given UNH's recent volatility history in the healthcare sector, the risk of mean reversion or fading into the close is material.

• CRMskipv1

  There are no recent headlines or company-specific catalysts to explain CRM's ~2.9% decline, making it difficult to assess whether the move reflects fundamental selling pressure or a broader market rotation. The macro context (elevated 5-year inflation expectations) is more relevant to commodities and TIPS than to a SaaS name like CRM, providing no directional edge. With 135 minutes remaining and no clear catalyst, mean-reversion is as plausible as continuation, warranting an uncertain stance.

• ABBVskipv1

  ABBV has made a strong 3.62% move with 135 minutes remaining, but there are no identifiable catalysts in recent headlines to explain or sustain the move, suggesting it may be a gap or block-driven event rather than a news-driven continuation. The macro context (elevated 5-year inflation expectations) is not directly supportive of large-cap pharma like ABBV, which is not a typical beneficiary of inflation-reactive sectors. Without a clear fundamental driver, mean-reversion or consolidation into the close is at least as likely as continuation, warranting an uncertain stance.

• NFLXskipv1

  NFLX is up 3.29% with no accompanying headlines or identifiable catalyst, suggesting this may be a gap or thin-volume move rather than a fundamentally-driven rally. The macro context points to elevated inflation expectations (T5YIE at 1.9σ above trend), which is not a tailwind for high-multiple growth names like NFLX. With 135 minutes remaining there is time for movement, but without a clear catalyst to sustain buying pressure, mean-reversion is equally plausible.

• JNJskipv1

  JNJ has moved up 2.38% with no identifiable headline catalyst driving the move, suggesting this could be a gap or sector rotation rather than a sustained fundamental shift. The macro context (elevated 5Y inflation breakevens at 1.9σ above trend) favors commodity and inflation-sensitive sectors like Energy and Gold, not healthcare defensives like JNJ — this could even act as a mild headwind for continuation. With 135 minutes remaining and no clear catalyst to sustain momentum, mean-reversion risk is elevated and confidence in continuation is low.

• LLYskipv1

  LLY is up ~3% intraday but there are no recent headlines or identifiable catalysts explaining the move, making it difficult to distinguish a sustained trend from a gap or thin-volume spike. The macro context (elevated 5Y inflation expectations) does not directly favor pharmaceutical/biotech names like LLY. With 135 minutes remaining, there is time for continuation, but without a clear news-driven catalyst, mean-reversion risk is meaningful and confidence in directional continuation is limited.

• AVGOskipv1

  AVGO is down ~4% with no recent headlines to explain the move, making it difficult to identify a clear catalyst supporting continuation. The macro context (elevated 5-year inflation expectations) is not directly bearish for semiconductors and doesn't provide a clear directional signal for AVGO specifically. With 135 minutes remaining and no fundamental news anchor, mean reversion is plausible, but the magnitude of the move and lack of context create too much uncertainty to confidently call direction.

11 candidates in trigger band, 0 entered, 11 skipped. Exits: 0.

• COSTskipv1

  COST is up 2.48% with no accompanying headlines or identifiable catalyst visible in today's session, making it difficult to attribute the move to a sustained fundamental driver versus a gap or thin-volume spike. The macro context (elevated 5-year inflation breakevens at 1.9σ above trend) is not a direct tailwind for consumer staples/warehouse retail like Costco and could even pressure margins if sustained. With 150 minutes remaining there is time for further movement, but without a clear catalyst the probability of meaningful continuation is insufficient to warrant a directional trade.

• UNHskipv1

  UNH is up 2.25% but there are no UNH-specific headlines or catalysts visible in the evidence to explain or support continuation of this move — the only headline references AMD and unrelated growth stocks. The macro context (elevated 5Y inflation expectations) is mildly negative for healthcare/managed care names as it pressures discount rates and cost assumptions, not a tailwind. With 150 minutes remaining there is time for a move, but without a clear fundamental catalyst driving this specific ticker, the rally looks more like a gap or sector rotation bounce that may fade rather than accelerate into the close.

• LLYskipv1

  LLY's 2.75% move lacks a clear company-specific catalyst in the available headlines, with the only recent news referencing AMD and growth stocks broadly. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is generally a headwind for high-multiple growth/pharma names like LLY. With 150 minutes remaining there is time for continuation, but without a confirmed fundamental catalyst the move may be mean-reverting or sector-driven noise.

• AMZNskipv1

  The -2.07% move in AMZN lacks a clear negative catalyst — recent headlines are broadly positive for big tech, highlighting strong AI demand and robust corporate profits, which would typically support AMZN's cloud/AWS segment. The macro context shows elevated 5-year inflation expectations (2.62, ~1.9σ above trend), which could weigh on growth equities, but this is not an acute single-day catalyst for AMZN specifically. With 150 minutes remaining, there is enough time for a partial mean-reversion as institutional buyers may step in given the positive sector narrative, making the downside continuation uncertain.

• JNJskipv1

  JNJ has moved up 2.23% today with no identifiable news catalyst visible in recent headlines, suggesting the move may be gap-driven or momentum-based rather than fundamentally supported. The macro context (elevated 5-year inflation expectations) is not particularly favorable for healthcare/defensive names like JNJ, which are not among the sectors typically reactive to T5YIE spikes. With 150 minutes remaining, there is time for either continuation or mean reversion, but the absence of a clear catalyst and the defensive nature of the stock suggest the move may fade or stall rather than extend meaningfully into the close.

• CRMskipv1

  There are no recent headlines or identifiable catalysts driving the ~3% decline in CRM today, making it difficult to assess whether selling pressure has a fundamental basis or is simply noise/sector rotation. The macro context (elevated 5-year inflation expectations) is more relevant to commodities and TIPS than enterprise software, providing no clear directional signal for CRM. With 150 minutes remaining and no catalyst to sustain directional momentum, mean reversion is roughly as likely as continuation, warranting an uncertain stance.

• NFLXskipv1

  The 3.21% intraday move in NFLX lacks an identifiable catalyst, as there are no recent headlines to explain the surge, raising the possibility this is a gap or volume spike without fundamental backing. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is not particularly supportive for high-multiple growth names like NFLX. With 150 minutes remaining, there is time for the move to either extend or mean-revert, but the absence of a clear news catalyst makes continuation uncertain and reduces conviction for a long-continuation trade.

• WMTskipv1

  The 2.57% gap up in WMT lacks a clear same-day catalyst visible in the headlines — the most recent news questions whether WMT is overvalued after recent gains, which is a mild headwind to continuation. With 150 minutes remaining there is time for movement, but without a fresh earnings beat or sector-specific catalyst the move looks more like a broad market lift (potentially tied to macro risk-on sentiment) rather than a stock-specific driver. The elevated 5Y inflation breakeven (2.62, 1.9σ above trend) is modestly supportive of consumer staples defensively but not a strong directional catalyst for WMT specifically into the close.

• ABBVskipv1

  ABBV is up 3.64% with no identifiable catalyst in recent headlines, suggesting this may be a gap-driven move without fresh fundamental support to sustain momentum into the close. The macro context (elevated 5Y inflation expectations) does not specifically benefit healthcare/pharma names like ABBV. With 150 minutes remaining, there is time for the move to extend, but absent a clear news catalyst and given the tendency for large gap-up moves without catalysts to partially fade mid-session, continuation is uncertain.

• AVGOskipv1

  There are no recent headlines or clear catalysts explaining the ~4% intraday decline in AVGO, making it difficult to assess whether the move is fundamentally driven or a transient dislocation. The macro context (elevated 5-year inflation expectations) is not directly bearish for semiconductor names like AVGO, and without a news catalyst, large intraday gaps often see partial mean reversion into the close. With 150 minutes remaining, there is sufficient time for either continuation or reversal, but the absence of a clear driver argues against high-conviction continuation.

• TSLAskipv1

  The -4.31% move lacks a clear single negative catalyst; headlines are mixed with Musk joining a Trump-Xi summit (potentially positive for trade/EV) and a Robotaxi rollout story testing optimism rather than confirming a miss. With 150 minutes remaining, there is meaningful time for a partial recovery, especially if the summit headline drives sentiment reversal. Elevated 5-year inflation expectations (2.62, 1.9σ above trend) create macro headwinds broadly but are not TSLA-specific, and the absence of a definitive negative catalyst suggests the move may stall or partially retrace rather than continue lower into the close.

11 candidates in trigger band, 0 entered, 11 skipped. Exits: 0.

• WMTskipv1

  WMT's 2.63% gap up lacks a clear intraday catalyst in the recent headlines — no earnings release, guidance update, or sector-specific news driving the move, which raises the possibility this is a gap-and-fade scenario. The macro backdrop of elevated 5-year inflation expectations (2.62, ~1.9σ above trend) is a mild headwind for consumer discretionary/staples multiples, and one headline explicitly questions whether WMT is overvalued after recent gains. With 165 minutes remaining there is time for continuation, but without a strong fundamental catalyst the risk of mean reversion or consolidation near the day's highs is meaningful.

• AVGOskipv1

  AVGO is down 4.55% with no recent headlines to explain the move, making it difficult to identify a clear catalyst for continuation. The macro context (elevated 5-year inflation expectations) is not directly bearish for semiconductors like AVGO. With 165 minutes remaining, there is meaningful time for a partial rebound or stabilization, especially absent a fundamental driver for the selloff.

• AMZNskipv1

  AMZN is down ~2.23% intraday but the news flow is broadly positive for big tech, with Wedbush highlighting strong AI demand across cloud and software — sectors where AMZN (AWS) is a direct beneficiary. This creates a potential reversal setup rather than continuation of the decline, especially with 165 minutes remaining which gives ample time for a recovery. The macro backdrop of elevated 5-year inflation expectations (2.62, nearly 2σ above trend) adds modest headwind to growth/tech names, but is not a strong enough catalyst to confidently sustain the sell-off into the close.

• ABBVskipv1

  ABBV is up 4% intraday with no accompanying headlines or identifiable catalyst visible in the data, suggesting this may be a gap or spike move without clear fundamental support for continuation. The macro context (elevated 5-year inflation expectations) is not directly relevant to a healthcare/pharma name like ABBV. With 165 minutes remaining there is time for continuation, but absent a clear catalyst, mean-reversion or consolidation is equally plausible, keeping conviction low.

• PEPskipv1

  PEP has moved up ~2.08% with no identifiable catalyst in recent headlines, suggesting the move may be driven by broader market sentiment or a gap rather than a specific fundamental driver. The macro context (elevated 5Y inflation breakevens) is not particularly bullish for a defensive consumer staples name like PEP, which could face margin pressure concerns. With 165 minutes remaining and no clear news catalyst, mean reversion or consolidation near current levels is as plausible as continuation.

• COSTskipv1

  COST is up 2.52% with no recent headlines to explain the catalyst, making it difficult to assess whether this move has fundamental support or is a momentum/gap-fill event. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is modestly supportive of consumer staples/warehouse retail like Costco as a defensive name, but this is not a direct catalyst. With 165 minutes remaining and no clear news driver, the risk of mean reversion is meaningful, warranting an uncertain stance rather than a high-confidence continuation call.

• CRMskipv1

  With no recent headlines or clear fundamental catalyst driving CRM's -2.61% decline today, the move lacks an identifiable narrative that would support high-confidence continuation. The macro context (elevated 5-year inflation expectations) is more relevant to commodities sectors like Gold and Energy than to enterprise software names like CRM, providing no directional edge. With 165 minutes remaining there is still meaningful time for mean reversion, and without a catalyst anchoring sellers, a partial recovery into the close is at least as likely as further downside.

• JNJskipv1

  JNJ has moved up 2.57% with no identifiable news catalyst or earnings event visible in recent headlines, suggesting this may be a gap-up or sector rotation move rather than a fundamentally-driven continuation. The macro context (elevated 5Y inflation expectations) is more relevant to Gold, Energy, and TIPS sectors than to healthcare/consumer staples like JNJ, providing no tailwind support. With 165 minutes remaining, there is time for movement, but without a clear catalyst and the risk of mean reversion on a news-vacuum gap, the probability of continuation is below threshold.

• NFLXskipv1

  The 3.78% intraday gain lacks a clearly visible positive catalyst — the only recent headline is a Texas lawsuit over data collection, which is a mild negative overhang that could weigh on sentiment as the session progresses. With 165 minutes remaining there is time for either continuation or reversal, but the absence of a confirmed bullish driver (no earnings beat, no upgrade, no sector tailwind) makes the move look potentially exhausted or technically driven. Elevated 5-year inflation expectations (2.62, ~1.9σ above trend) also create a macro headwind for high-multiple growth names like NFLX, further undermining conviction in upside continuation.

• LLYskipv1

  LLY's 2.78% intraday gain lacks a clear stock-specific catalyst in the available headlines, which focus on AMD and unrelated growth stocks. The macro context flags elevated inflation expectations (T5YIE at 1.9σ above trend), which is generally neutral-to-negative for high-multiple pharma names like LLY. With 165 minutes remaining there is time for the move to extend, but without a confirmed fundamental driver the gain could represent profit-taking territory or a broader market lift that may fade into the close.

• TSLAskipv1

  The ~5% intraday decline lacks a clear single negative catalyst — headlines are mixed, with Musk joining a high-profile Trump-Xi summit (potentially positive) and robotaxi/EV growth news that is sentiment-neutral to slightly positive. The macro context of elevated 5Y inflation breakevens (T5YIE at 1.9σ above trend) creates a modest headwind for high-multiple growth names like TSLA, but is not a direct trigger. With 165 minutes remaining, there is time for a partial mean-reversion bounce, especially given the absence of a decisive bearish catalyst and the possibility that the summit news provides a late-session lift.

11 candidates in trigger band, 0 entered, 11 skipped. Exits: 0.

• AMZNskipv1

  The -2.20% move in AMZN lacks a clear company-specific negative catalyst; recent headlines are broadly constructive for big tech with Wedbush reinforcing AI demand strength and corporate profits at multi-year highs. With 3 hours remaining, there is meaningful time for a reversal, especially given the positive sector backdrop that could attract dip buyers. The elevated 5-year inflation breakeven (2.62, ~1.9σ above trend) adds some macro headwind for growth names, but is insufficient alone to sustain the selloff into the close.

• PEPskipv1

  PEP has moved up ~2.07% with no identifiable catalyst from recent headlines, suggesting this may be a gap or thin-volume drift rather than a news-driven momentum move. The macro context (elevated 5-year inflation expectations) is not directly favorable for a defensive consumer staples name like PEP, as rising inflation breakevens can pressure valuation multiples on low-growth dividend payers. With 180 minutes remaining there is time for mean reversion, and without a clear fundamental catalyst supporting continuation, the probability of further upside into the close is below the threshold for a high-conviction trade.

• CRMskipv1

  There are no recent headlines or clear catalysts driving CRM's -2.37% decline today, making it difficult to assess whether selling pressure will persist into the close. The macro context (elevated 5-year inflation expectations) is most relevant to commodities and TIPS sectors, not directly to enterprise software like CRM. With 180 minutes remaining and no identifiable news catalyst, the move could reflect broad market noise or sector rotation, but lacks the fundamental support needed to assign high continuation probability.

• ABBVskipv1

  ABBV has moved up 3.40% today with no accompanying news catalysts visible, suggesting this could be a gap or technical move without a clear fundamental driver sustaining it. The macro context (elevated 5-year inflation expectations) is more relevant to commodities and TIPS sectors than healthcare/pharma, providing no directional tailwind. With 180 minutes remaining there is time for movement, but absent a catalyst and with a sizable move already priced in, mean reversion risk is meaningful.

• LLYskipv1

  LLY has moved up 2.75% today but there is no direct LLY-specific catalyst visible in the provided headlines — the AMD/growth stock headline is not a meaningful driver for a large-cap pharma/biotech name. The macro context shows elevated inflation expectations (T5YIE at 1.9σ above trend), which is generally a headwind for high-multiple growth stocks like LLY rather than a tailwind. With 180 minutes remaining, there is time for movement, but without a clear fundamental catalyst supporting continuation, mean reversion or consolidation is equally plausible.

• TSLAskipv1

  The -4.90% decline in TSLA today lacks a clear single catalyst driving sustained selling pressure — headlines are mixed, with a Musk/Trump/Xi summit appearance potentially a mild positive and the robotaxi rollout story neutral-to-positive longer term. With 180 minutes remaining, there is ample time for either continuation or mean reversion, but elevated inflation expectations (T5YIE at 1.9σ above trend) create a risk-off macro backdrop that could weigh on high-beta growth names like TSLA. Given the ambiguous news flow and no definitive bearish catalyst confirmed, a full continuation into the close is not high-conviction, making this setup uncertain rather than a clear directional trade.

• NFLXskipv1

  The 4.29% move up in NFLX lacks a clearly identifiable positive catalyst in the headlines — in fact, the most recent news is mildly negative (Texas lawsuit over data collection). With 180 minutes remaining, there is time for movement, but without a clear fundamental driver (earnings beat, upgrade, or sector tailwind), the initial gap may fade or consolidate rather than continue. The elevated inflation expectations macro environment (T5YIE at 1.9σ above trend) does not directly support growth/tech names like NFLX, adding a modest headwind to further upside.

• AVGOskipv1

  The -4.50% drop in AVGO lacks a clear direct catalyst in today's headlines; the Micron memory chip shortage news is net positive for semiconductors and could attract dip buyers into AVGO as a related AI/semiconductor name. The macro context shows elevated 5-year inflation expectations (2.62, +1.9σ), which is not a direct headwind for semiconductor equities. With 180 minutes remaining and no specific negative catalyst identified for AVGO, a partial mean-reversion or stabilization is plausible, making continuation of the downside move uncertain.

• JNJskipv1

  JNJ has moved up 2.49% with no identifiable catalyst from recent headlines, suggesting this may be a gap or technical move rather than news-driven momentum. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is not particularly supportive of defensive healthcare names like JNJ. With 180 minutes remaining and no clear fundamental driver, the risk of mean reversion or consolidation is elevated, making continuation uncertain.

• COSTskipv1

  COST is up 2.30% with no recent news headlines to explain the move, making it difficult to attribute the gain to a clear catalyst that would sustain buying pressure into the close. The macro context highlights elevated 5-year inflation expectations (2.62, ~1.9σ above trend), which is more relevant to Gold, Energy, and TIPS than to a consumer staples/warehouse retailer like Costco. With 180 minutes remaining and no identifiable fundamental driver, the move could easily mean-revert as intraday momentum fades or profit-taking sets in.

• WMTskipv1

  WMT has already moved +2.43% today without a clear fresh catalyst — no earnings release, no major company-specific news driving the move, and the only recent headline questions whether the stock is overvalued after recent gains. With 3 hours remaining, there is time for continuation, but the absence of a identifiable catalyst suggests this may be a gap or sympathy move tied to broader market strength (Dow firm) rather than a durable intraday trend. Elevated 5-year inflation expectations (T5YIE at 1.9σ above trend) could modestly support consumer staples as an inflation-resistant sector, but this macro factor is not strong enough alone to justify a high-conviction continuation call.

9 candidates in trigger band, 0 entered, 9 skipped. Exits: 0.

• JNJskipv1

  JNJ is up 2.23% but there is no clear earnings catalyst or major news driving today's move — the only recent headline is a conference participation announcement, which is a soft catalyst at best. With 195 minutes remaining the stock has time to move further, but the macro context (elevated 5Y inflation expectations at 1.9σ above trend) is generally unfavorable for defensive healthcare names via discount rate pressure. Without a strong identifiable catalyst, the move likely reflects sector rotation or broad market tailwinds rather than a durable stock-specific driver, making continuation uncertain.

• CRMskipv1

  There are no recent headlines or clear catalysts explaining the -2.06% move in CRM today, making it difficult to assess whether this is a fundamental-driven decline or noise/sector rotation. The macro context (elevated 5-year inflation expectations) is more relevant to commodities and TIPS than enterprise software like CRM, providing no directional edge. With 195 minutes remaining and no identifiable catalyst, the move could easily mean-revert into the close, warranting an uncertain stance.

• AMZNskipv1

  The -2.06% move in AMZN lacks a clear AMZN-specific negative catalyst; recent headlines are broadly positive for big tech and AI demand, suggesting the decline may reflect broader market rotation or profit-taking rather than fundamental deterioration. The macro context shows elevated 5-year inflation expectations (2.62, ~1.9σ above trend), which could pressure growth/tech names, but this is a diffuse headwind rather than a sharp catalyst. With 195 minutes remaining and no identifiable stock-specific driver, the move is more likely a mean-reversion candidate than a continuation, warranting an uncertain stance.

• ABBVskipv1

  ABBV has already moved 3.19% intraday with no identifiable headline catalyst, suggesting this may be a gap-and-fade or thin-volume spike rather than a news-driven momentum move. The macro context (elevated inflation expectations via T5YIE) is not particularly favorable or unfavorable for a large-cap pharma/biotech like ABBV. With 195 minutes remaining and no clear catalyst to sustain the move, mean reversion is a plausible outcome, making continuation uncertain.

• LLYskipv1

  LLY is up ~2.9% with no direct catalyst visible in the available headlines — the AMD/growth-stock headline is unrelated to LLY's pharma fundamentals, offering no clear sector tailwind. The macro backdrop shows elevated 5-year inflation expectations (2.62, ~1.9σ above trend), which can pressure growth/high-multiple names like LLY near-term rather than support them. With 195 minutes remaining, there is time for the move to extend, but without a confirmed catalyst (earnings beat, clinical data, FDA approval) the gap looks more like a sympathy or broad market lift, suggesting mean-reversion risk is meaningful.

• WMTskipv1

  WMT's 2.26% gain lacks a clear intraday catalyst — no earnings release or major company-specific news today, and the most recent headline questions whether WMT is overvalued after recent gains, which is a mild headwind to continuation. The macro context (elevated 5Y breakeven inflation at 1.9σ above trend) is not particularly favorable for a high-multiple defensive consumer staple like WMT, as rising inflation expectations can compress valuation multiples. With 195 minutes remaining there is time for a move, but without a strong catalyst the gap-up is likely to fade or consolidate rather than extend meaningfully into the close.

• AVGOskipv1

  AVGO is down ~4% but there is no direct negative catalyst visible in the headlines — the only recent semiconductor news (Micron rally on memory chip shortage) is actually sector-positive, suggesting AVGO's drop may be idiosyncratic or broader macro-driven rather than a fresh catalyst for continuation. The elevated inflation expectations (T5YIE at 1.9σ above trend) could weigh on growth/tech names, but this is a diffuse macro headwind rather than a ticker-specific driver. With 195 minutes remaining and no clear fundamental catalyst sustaining the sell-off, a partial mean-reversion into the close is plausible, making continuation uncertain.

• TSLAskipv1

  The ~4% decline lacks a clear strong negative catalyst — the headlines are mixed to neutral (Musk joining Trump-Xi summit is arguably a positive geopolitical angle, robotaxi news is forward-looking but ambiguous). With 195 minutes remaining, there is meaningful time left in the session, but without a definitive bearish catalyst the move could reflect broader market pressure or profit-taking that may partially reverse. Elevated 5Y inflation expectations (2.62, ~1.9σ above trend) create a macro headwind for high-multiple growth names like TSLA, but this is not a sharp new development sufficient to confirm aggressive continuation.

• NFLXskipv1

  The 4.06% upward move lacks a clear positive catalyst visible in recent headlines — in fact, the most recent news is a Texas lawsuit over data collection, which is a mild headwind. With no confirmed earnings beat, product announcement, or sector tailwind directly supporting NFLX, the move may reflect broader market momentum or pre-session activity rather than a sustained catalyst. The elevated inflation expectations (T5YIE at 1.9σ above trend) create a slightly risk-off macro backdrop that does not favor continuation in a growth/streaming name over the remaining 195 minutes.

6 candidates in trigger band, 0 entered, 6 skipped. Exits: 0.

• TSLAskipv1

  The 3.81% decline in TSLA lacks a clear negative catalyst from recent headlines — in fact, Musk joining Trump for a Xi summit could be read as a positive geopolitical signal for Tesla's China business, which may attract dip buyers. The macro context of elevated 5-year inflation expectations (2.62, 1.9σ above trend) is not a direct TSLA headwind and the robotaxi/Korea EV headline is mildly constructive. With 210 minutes remaining the move could reverse or stabilize rather than accelerate lower, making a clean continuation call difficult.

• NFLXskipv1

  NFLX is up ~3.94% with 210 minutes remaining, a meaningful move with time still on the clock, but the most recent headline — a Texas lawsuit over data collection — adds a regulatory overhang that could cap further upside or draw selling pressure. The macro context (elevated 5Y breakeven inflation at 2.62, 1.9σ above trend) is not a direct tailwind for growth/tech names like NFLX, and may subtly weigh on sentiment. Without a clear positive catalyst such as an earnings beat or analyst upgrade driving today's move, and with active legal news creating uncertainty, the risk/reward for continuation is insufficiently skewed to justify a high-probability continuation call.

• AVGOskipv1

  AVGO is down 3.45% with no direct company-specific catalyst visible in recent headlines — the Micron rally on memory chip shortage actually suggests AI semiconductor demand is broadly positive, which could support a partial mean reversion into the close. The macro context shows elevated inflation expectations (T5YIE at 1.9σ above trend), which is mildly negative for high-multiple tech names like AVGO but is not a fresh intraday catalyst. With 210 minutes remaining, there is ample time for a reversal, but without a clear bearish catalyst driving the selloff, the move lacks the conviction needed to bet on continuation.

• WMTskipv1

  WMT's 2.01% move lacks a clear intraday catalyst — no earnings release or major news today, and yesterday's headlines question valuation after recent gains, suggesting the move may be profit-taking reversal risk rather than momentum continuation. The macro context (elevated 5Y inflation expectations at 1.9σ above trend) is marginally supportive of consumer staples/defensive names like WMT as an inflation hedge, but this is a weak tailwind. With 210 minutes remaining there is time for continuation, but the absence of a fresh catalyst and overvaluation concerns make follow-through uncertain.

• ABBVskipv1

  ABBV is up ~2.93% with no accompanying headlines or identifiable catalyst, suggesting the move may be driven by broader market sentiment or a gap that has already largely played out. The macro context highlights elevated inflation expectations (T5YIE 1.9σ above trend), which is not a direct tailwind for healthcare/pharma names like ABBV. With 210 minutes remaining there is time for the move to extend, but without a clear fundamental catalyst, mean reversion or consolidation is equally plausible.

• LLYskipv1

  LLY is up 2.59% today but there is no clear LLY-specific catalyst in the recent headlines — the only headline references AMD and general growth stocks, providing no direct support for continued pharmaceutical sector momentum. The macro backdrop shows elevated 5-year inflation expectations (2.62, ~1.9σ above trend), which is more of a headwind for high-valuation growth/biotech names like LLY than a tailwind. With 210 minutes remaining, there is time for further movement, but without a stock-specific catalyst the move may be consolidation or mean-reversion territory rather than a clean continuation setup.

1 trigger(s), 0 bought, 1 skipped, 0 analyze failures, 1 watch-listed. Exits: 0.

• NFLXskip-18.6% off 30d highp=0.38v1

  Netflix's fundamentals remain strong — Q1 2026 showed $10.5B in revenue, $2.89B net income, and $9B in cash, with healthy operating cash flow. However, the 18.6% drop from the 30-day high appears to carry meaningful idiosyncratic stress beyond today's broad market weakness (QQQ -1.84%, IWM -2.25%): a Texas lawsuit alleging data collection violations and child privacy harms is a regulatory overhang that could linger well beyond 90 days, and the price increase to $20 for the ad-free tier signals potential subscriber sensitivity. The macro backdrop with elevated inflation expectations (T5YIE at 1.9σ above trend) further pressures consumer discretionary and growth names.

0 exits, no candidates in trigger band.

• portfoliolog

  No universe names in the 2-5% intraday move band.

5 pressure candidate(s), 0 opened, 5 skipped. Exits: 0.

1 trigger(s), 0 bought, 1 skipped, 0 analyze failures, 1 watch-listed. Exits: 0.

• NFLXskip-18.6% off 30d highp=0.38v2

  Netflix's fundamentals remain strong — Q1 2026 10-Q shows $10.5B revenue, $2.9B net income, and $9B cash, suggesting no financial deterioration. However, the 18.6% drop from the 30-day high appears to have idiosyncratic catalysts: a Texas state lawsuit alleging data collection/privacy violations involving children, which introduces meaningful legal and regulatory overhang beyond typical macro noise. The broad market is also under pressure today (QQQ -1.84%, IWM -2.25%), so some of the decline is macro-driven, but the lawsuit news is stock-specific and material enough to suppress a near-term rebound.

1 trigger(s), 0 bought, 1 skipped, 0 analyze failures, 1 watch-listed. Exits: 0.

• NFLXskip-18.6% off 30d highp=0.41v1

  Netflix's most recent 10-Q shows robust fundamentals: $10.5B in quarterly revenue, $2.9B net income, and $9B in cash, indicating no financial deterioration justifying an 18.6% pullback. The drop appears driven by macro headwinds (elevated 5-year inflation expectations at 1.9σ above trend pressuring growth multiples) and headline noise from the Texas lawsuit, which is a regulatory nuisance rather than an existential threat. However, at $88.69 the stock's implied valuation must be checked against its earnings power — the low EPS of $0.66 on otherwise strong income suggests possible one-time charges or share-count dynamics worth monitoring, and the price-to-earnings multiple at this level may still be elevated given macro conditions.

Ratio 56.12, in-band. Holding GLD.

• portfoliohold

  Ratio 56.12 is inside [50, 80]; holding GLD.

Weinstein run: 0 closes, 0 entries. 0 candidates considered.

• portfoliolog

  Already at target 10 positions; no entries.

Weinstein run: 0 closes, 0 entries. 0 candidates considered.

• portfoliolog

  Already at target 10 positions; no entries.

1 trigger(s), 0 bought, 1 skipped, 0 analyze failures, 1 watch-listed. Exits: 0.

• NFLXskip-18.7% off 30d highp=0.38v1

  Netflix's Q1 2026 10-Q shows strong fundamentals: $10.5B revenue, $2.9B net income, and $9B in cash — no signs of financial deterioration. However, the 18.7% drop from the 30-day high appears partially idiosyncratic (Texas lawsuit over data collection/child privacy, pricing pressure commentary) layered on top of a notably weak macro tape today (QQQ -1.89%, IWM -2.31%, elevated VXX), and elevated 5Y inflation expectations (T5YIE at 1.9σ above trend) create a headwind for growth multiples. The Texas lawsuit introduces regulatory/legal tail risk that the market is repricing, and at $88.63, NFLX appears to have undergone a meaningful re-rating rather than a simple dip in an otherwise healthy trend.

0 exits, no candidates in trigger band.

• portfoliolog

  No universe names in the 2-5% intraday move band.

5 pressure candidate(s), 1 opened, 4 skipped. Exits: 0.

• CRMbuy

  PUT on CRM — 5-day return -7.06% with close below 20-day MA ($181.59). IV 48.2%. Sized 1 contract(s) at $9.89 premium.

1 trigger(s), 0 bought, 1 skipped, 0 analyze failures, 1 watch-listed. Exits: 0.

• NFLXskip-18.7% off 30d highp=0.41v2

  Netflix's fundamentals remain solid — Q1 2026 showed $10.5B in revenue, $2.9B net income, strong operating cash flow, and $9B in cash, indicating no financial deterioration. The 18.7% drop from the 30-day high appears driven by idiosyncratic headwinds: a high-profile Texas lawsuit over data collection/privacy (a real but not existential risk) and a broad risk-off session with QQQ down 1.89% and IWM down 2.31% compounding the move. However, the macro environment is unfavorable — elevated 5-year inflation expectations (2.62, 1.9σ above trend) compress growth multiples, and the lawsuit introduces regulatory/legal uncertainty that could linger well beyond a 90-day window.

1 trigger(s), 0 bought, 1 skipped, 0 analyze failures, 1 watch-listed. Exits: 0.

• NFLXskip-18.7% off 30d highp=0.41v1

  Netflix's most recent 10-Q shows solid fundamentals: EPS of $0.66, revenue of ~$10.5B, net income of ~$2.9B, and operating cash flow of ~$2.8B with ~$9B in cash — no signs of financial deterioration. The 18.7% pullback appears driven primarily by macro headwinds (elevated 5-year inflation expectations at 1.9σ above trend pressuring growth multiples) and headline risk from the Texas lawsuit, rather than fundamental business deterioration. However, at $88.63 the price level relative to recent history raises questions about where the stock was trading before the 30-day window, and the lawsuit combined with rising streaming cost narrative introduces non-trivial near-term overhang.

Ratio 56.14, in-band. Holding GLD.

• portfoliohold

  Ratio 56.14 is inside [50, 80]; holding GLD.

Weinstein run: 0 closes, 1 entry. 10 candidates considered.

• CBOElog

  Stage 2: close $354.12 > MA150 $273.12 (+29.7%), MA rising, 0.1% off 52w high, vol 0.09× avg

• NXPIlog

  Stage 2: close $292.61 > MA150 $222.31 (+31.6%), MA rising, 4.5% off 52w high, vol 0.05× avg

• FTNTlog

  Stage 2: close $114.47 > MA150 $82.89 (+38.1%), MA rising, 1.5% off 52w high, vol 0.03× avg

• GOOGlog

  Stage 2: close $384.42 > MA150 $310.11 (+24.0%), MA rising, 3.5% off 52w high, vol 0.01× avg

• GEHClog

  Stage 4: close $61.94 < MA150 $76.49 (-19.0%), MA falling, 31.0% off 52w high, vol 0.02× avg

• ZMlog

  Stage 2: close $103.34 > MA150 $85.72 (+20.6%), MA rising, 7.4% off 52w high, vol 0.04× avg

• SBUXlog

  Stage 2: close $106.34 > MA150 $91.52 (+16.2%), MA rising, 1.6% off 52w high, vol 0.02× avg

• ROKUlog

  Stage 2: close $125.99 > MA150 $102.07 (+23.4%), MA rising, 4.1% off 52w high, vol 0.02× avg

• CTSHlog

  Stage 4: close $48.32 < MA150 $70.19 (-31.2%), MA falling, 44.5% off 52w high, vol 0.04× avg

• LRCXlog

  Stage 2: close $280.30 > MA150 $203.81 (+37.5%), MA rising, 6.6% off 52w high, vol 0.02× avg

• AMATlog

  Stage 2: close $419.50 > MA150 $309.65 (+35.5%), MA rising, 6.5% off 52w high, vol 0.04× avg

Weinstein run: 0 closes, 1 entry. 10 candidates considered.

• ROKUlog

  Stage 2: close $125.99 > MA150 $102.07 (+23.4%), MA rising, 4.1% off 52w high, vol 0.02× avg

• AMATlog

  Stage 2: close $419.50 > MA150 $309.65 (+35.5%), MA rising, 6.5% off 52w high, vol 0.04× avg

• GOOGlog

  Stage 2: close $384.42 > MA150 $310.11 (+24.0%), MA rising, 3.5% off 52w high, vol 0.01× avg

• LRCXlog

  Stage 2: close $280.30 > MA150 $203.81 (+37.5%), MA rising, 6.6% off 52w high, vol 0.02× avg

• CBOElog

  Stage 2: close $354.12 > MA150 $273.12 (+29.7%), MA rising, 0.1% off 52w high, vol 0.09× avg

• SBUXlog

  Stage 2: close $106.34 > MA150 $91.52 (+16.2%), MA rising, 1.6% off 52w high, vol 0.02× avg

• NXPIlog

  Stage 2: close $292.61 > MA150 $222.31 (+31.6%), MA rising, 4.5% off 52w high, vol 0.05× avg

• ZMlog

  Stage 2: close $103.34 > MA150 $85.72 (+20.6%), MA rising, 7.4% off 52w high, vol 0.04× avg

• FTNTlog

  Stage 2: close $114.47 > MA150 $82.89 (+38.1%), MA rising, 1.5% off 52w high, vol 0.03× avg

• CTSHlog

  Stage 4: close $48.32 < MA150 $70.19 (-31.2%), MA falling, 44.5% off 52w high, vol 0.04× avg

• GEHClog

  Stage 4: close $61.94 < MA150 $76.49 (-19.0%), MA falling, 31.0% off 52w high, vol 0.02× avg

8 candidates in trigger band, 0 entered, 8 skipped. Exits: 0.

• WMTskipv1

  WMT's 2.26% move lacks a clear same-day catalyst in the headlines; the most recent coverage questions whether the stock is already overvalued after recent gains, which could cap further upside. The macro context shows elevated 5-year inflation expectations (2.62, ~1.9σ above trend), which is modestly supportive of defensive consumer staples like WMT but is not a direct sector tailwind. With 225 minutes remaining and no earnings release or strong fundamental catalyst visible, the move looks more like a broader market lift than a stock-specific driver, making continuation uncertain and unworthy of a high-conviction long.

• LLYskipv1

  LLY has moved up 2.72% today but there is no LLY-specific headline or catalyst in the evidence provided to explain or support continuation of this move — the only headline references AMD and growth stocks broadly, which is insufficient to anchor a high-conviction directional call. The macro context (elevated 5-year inflation expectations at 1.9σ above trend) is modestly unfavorable for high-multiple pharmaceutical/biotech names like LLY as it pressures discount rates. With 225 minutes remaining there is time for a move, but without a clear fundamental catalyst the gap-and-hold pattern is uncertain and mean reversion is equally plausible.

• COSTskipv1

  COST is up 2.26% with no recent headlines to explain the catalyst, making it difficult to assess whether this move is driven by fundamental news or technical/flow factors. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is not a clear tailwind for a consumer staples/warehouse retailer like Costco. With 225 minutes remaining, there is ample time for either continuation or mean reversion, but the absence of a clear catalyst and mildly unfavorable macro backdrop (higher real rates/inflation expectations tend to pressure growth-sensitive retail multiples) suggests caution rather than a high-conviction continuation trade.

• ORCLskipv1

  ORCL is down nearly 5% intraday but there is no clear catalyst in the available headlines directly tied to Oracle — the AMD headline is unrelated and offers no directional signal for ORCL. With 225 minutes remaining until the forced close, there is meaningful time left, but without a confirmed fundamental driver (earnings miss, guidance cut, sector-specific news), the move could reflect broader tech rotation or a gap that partially fills. Elevated inflation expectations (T5YIE 1.9σ above trend) create a mildly unfavorable macro backdrop for high-multiple tech names, but not enough conviction to call continuation with confidence.

• TSLAskipv1

  The decline appears partly driven by broader macro pressures (elevated 5Y inflation breakevens at 1.9σ above trend suggesting risk-off tilt) rather than a clear TSLA-specific negative catalyst. The Musk/Cook Xi Summit headline is ambiguous and could be interpreted as a positive trade tension development, creating a potential floor. With 225 minutes remaining, there is meaningful time for reversal, and TSLA's high beta means intraday swings of this magnitude frequently see partial mean-reversion without a strong directional catalyst to sustain the move.

• NFLXskipv1

  The 3.93% intraday gain lacks a clear positive catalyst to sustain it — the only recent headline is negative (Texas lawsuit over data collection), which actually creates a headwind against continuation. With 225 minutes remaining there is ample time for the move to extend or reverse, but the absence of a fundamental driver (e.g., earnings beat, analyst upgrade, sector tailwind) and the presence of litigation overhang suggest the gap-up may fade. Elevated inflation expectations (T5YIE at 1.9σ above trend) are macro-neutral to slightly negative for growth equities like NFLX, further reducing confidence in continuation.

• AVGOskipv1

  AVGO is down 3.65% but the available headlines reference Micron and memory chip strength for AI, which could actually provide a sector tailwind that partially offsets AVGO's decline rather than confirming continuation downward. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is a headwind for high-multiple semiconductor names but is not a fresh catalyst specific to AVGO today. With 225 minutes remaining and no clear AVGO-specific negative catalyst identified, the move could reflect broad risk-off or sector rotation rather than a persistent directional driver, making continuation uncertain.

• ABBVskipv1

  ABBV has moved up 3.27% with no identifiable news catalyst in the recent headlines, suggesting this may be a gap or early-session move without a clear fundamental driver to sustain momentum into the close. The macro context (elevated 5-year inflation expectations) is not directly relevant to ABBV as a pharmaceutical stock. With 225 minutes remaining, there is time for either continuation or mean reversion, but the absence of a catalyst makes high-conviction continuation unlikely.

9 candidates in trigger band, 0 entered, 9 skipped. Exits: 0.

• NFLXskipv1

  The 3.87% intraday gain lacks a clear positive catalyst visible in recent headlines; in fact, the most recent news is a Texas lawsuit over data collection, which is a mild negative overhang that could cap further upside or invite selling into strength. With 240 minutes remaining the day is still young, but the absence of a confirmatory bullish catalyst (earnings beat, upgrade, or sector tailwind) combined with active litigation news makes continuation less reliable. The elevated inflation expectations macro backdrop (T5YIE at 1.9σ above trend) is not particularly favorable for high-multiple growth names like NFLX, adding further uncertainty to the continuation thesis.

• TSLAskipv1

  The -3.47% move lacks a clear single dominant catalyst — headlines are mixed, with Musk joining Trump for a Xi summit (potentially constructive for Tesla's China exposure) and a robotaxi rollout story that could be read either way. With 240 minutes remaining, there is meaningful time for a reversal, and the positive geopolitical headline (US-China summit with Musk/Cook) could attract dip buyers mid-session. Elevated 5Y inflation expectations (2.62, ~1.9σ above trend) create a modest headwind for high-multiple growth names like TSLA, but is not a strong enough macro signal alone to confirm continuation of the selloff into the close.

• AMDskipv1

  The headlines are broadly constructive for AMD — a 'server CPU supercycle' call and Wedbush reinforcing AI chip demand suggest the -4.37% drop is more likely a broader market reaction or profit-taking than a fundamental deterioration. With 240 minutes remaining, there is meaningful time for a partial recovery, especially given the positive sector narrative. However, elevated inflation expectations (T5YIE at 1.9σ above trend) could weigh on growth/chip multiples, limiting the reversal conviction to below a high-confidence threshold.

• AVGOskipv1

  AVGO is down ~3% but the only relevant headline is a Micron rally on memory chip demand, which is tangentially positive for the semiconductor sector and could provide a headwind against further AVGO declines. The macro context (elevated 5Y inflation expectations) is not a direct catalyst for semiconductor weakness. With 240 minutes remaining there is ample time for reversal, and the absence of a clear AVGO-specific negative catalyst makes continuation of the downward move less probable than a partial mean reversion.

• ORCLskipv1

  The ~4.9% decline in ORCL lacks a clear catalyst in the provided headlines, which focus on AMD and other growth stocks rather than ORCL-specific news. With 240 minutes remaining, there is meaningful time for either continuation or mean reversion, but without a fundamental driver (earnings miss, guidance cut, or sector-specific headwind) the move appears ambiguous. The elevated inflation expectations (T5YIE at 1.9σ above trend) could weigh on high-multiple tech names generally, but this macro signal is non-specific and insufficient to confidently call continuation.

• ABBVskipv1

  ABBV has moved up 2.86% with no identifiable catalyst from recent headlines, suggesting the move may be driven by broader market sentiment or sector rotation rather than a company-specific event. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is not particularly favorable for large-cap pharma/biotech names like ABBV. With 240 minutes remaining and no clear fundamental driver, there is meaningful risk of mean reversion or profit-taking into the close, making continuation uncertain.

• LLYskipv1

  LLY's 2.34% intraday gain lacks a clear LLY-specific catalyst in the provided headlines, which reference AMD and unrelated macro factors — suggesting the move may be sector rotation or broad market lift rather than a fundamental driver. The elevated T5YIE inflation expectation (2.62, nearly 2σ above trend) creates a macro headwind for high-multiple growth/pharma names like LLY, as rate-sensitive valuations face compression pressure. With 240 minutes remaining there is ample time for either direction, but absent a clear LLY-specific catalyst the move is difficult to confidently project as continuing.

• COSTskipv1

  COST is up 2.10% with no identifiable news catalyst driving the move, making it difficult to assess whether the gain reflects genuine buying conviction or a gap that may fade. The macro context highlights elevated 5-year inflation expectations (T5YIE at 2.62, 1.9σ above trend), which is more directly relevant to commodity-linked sectors like Gold and Energy rather than consumer staples/retail like Costco. With 240 minutes remaining, there is time for the move to extend, but without a clear fundamental catalyst and no supporting headlines, the probability of meaningful continuation is below the threshold for a high-confidence trade.

• WMTskipv1

  WMT's 2.01% move lacks a clear intraday catalyst — the headlines are soft (a small brand launch, a valuation-skepticism piece, and an unrelated market recap), suggesting the move may be macro/sector-driven rather than company-specific. The elevated 5-year inflation breakeven (2.62, +1.9σ) could provide mild support for consumer staples like WMT as an inflation-defensive name, but also signals broader macro uncertainty. With 240 minutes remaining and no strong fundamental catalyst, the probability of meaningful continuation is roughly coin-flip, and the overvaluation narrative in recent coverage could invite profit-taking into the close.

9 candidates in trigger band, 0 entered, 9 skipped. Exits: 0.

• WMTskipv1

  The 2.24% move in WMT lacks a clear same-day catalyst — the headlines are either neutral (overvaluation concern, general market coverage) or minor (a small brand securing shelf space). With ~255 minutes remaining the session is still early, but the macro backdrop of elevated 5-year inflation expectations (2.62, ~1.9σ above trend) could pressure consumer-staple valuations, creating a headwind for further gains. Given the absence of a strong fundamental driver and a potentially stretched valuation narrative already circulating, the move looks more like broad market lift than a stock-specific catalyst, suggesting mean-reversion risk rather than continuation.

• JNJskipv1

  The 2.12% move in JNJ lacks a clear intraday catalyst — the only relevant headline is a routine conference participation announcement, which is not typically a meaningful price mover. With no earnings beat, analyst upgrade, or sector-specific news driving the move, this looks more like a gap or sector rotation rather than a sustained trend. The macro context (elevated 5Y inflation expectations) is more relevant to commodities and TIPS than healthcare, providing no additional tailwind for JNJ continuation.

• ABBVskipv1

  ABBV has moved up 3.43% today with no accompanying news headlines to explain the catalyst, suggesting the move may be driven by sector rotation, options activity, or a gap that lacks fundamental support. With 255 minutes remaining there is time for continuation, but without a clear identifiable catalyst the probability of sustained momentum is moderate at best. The macro context (elevated inflation expectations) is not directly favorable for large-cap pharma, and absent a news driver, mean reversion risk is meaningful after a move of this magnitude.

• LLYskipv1

  LLY is up ~2.93% today but there is no clear LLY-specific catalyst in the recent headlines — the only headline references AMD and growth stocks broadly, which is tangential at best. The macro context highlights elevated 5-year inflation expectations (2.62, ~1.9σ above trend), which is not a direct tailwind for large-cap pharma/biotech and could weigh on rate-sensitive growth valuations. With ~255 minutes remaining the session is still early, but absent a clear fundamental catalyst the move looks potentially momentum-driven or sector-rotation-based, making continuation uncertain.

• NFLXskipv1

  The 3.78% intraday gain lacks a clear positive catalyst visible in recent headlines; the only news is a Texas lawsuit over data collection which pushed shares lower yesterday, suggesting today's move may be a technical bounce or short-covering rather than fundamental re-rating. The macro backdrop shows elevated 5-year inflation expectations (2.62, nearly 2σ above trend), which is a mild headwind for high-multiple growth/tech names like NFLX. With 255 minutes remaining the day is still long, but without a confirming catalyst and an active litigation overhang, the probability of sustained continuation into the close is below threshold.

• AVGOskipv1

  AVGO is down ~3.7% but there is no direct negative catalyst visible for the stock — the only recent headline is a positive memory chip/AI demand story for Micron, which could provide sector tailwinds that partially offset selling pressure. The macro context (elevated 5Y inflation breakeven at 1.9σ above trend) is not a clear near-term driver for AVGO specifically. With 255 minutes remaining the day is still young and a mean-reversion bounce is plausible absent a confirmed negative catalyst, making continuation of the downside move uncertain.

• COSTskipv1

  COST is up 2.37% with no recent headlines to explain the catalyst, making it difficult to assess whether this move has fundamental backing or is driven by broader market momentum. The macro context highlights elevated inflation expectations (T5YIE at 1.9σ above trend), which is not a direct tailwind for a consumer staples/warehouse retailer like Costco. With 255 minutes remaining, there is time for the move to continue, but without a clear catalyst such as earnings, guidance, or sector news, mean reversion is equally plausible.

• AMDskipv1

  The -4.62% decline in AMD appears to be in tension with strongly bullish sector headlines, including a 'server CPU supercycle' call and Wedbush reinforcing AI demand strength — suggesting the drop may reflect broader market rotation or profit-taking rather than a fundamental deterioration. With 255 minutes remaining, there is meaningful time for a reversal, especially given the positive news backdrop and no clear negative catalyst specific to AMD. The macro inflation signal (elevated 5Y breakeven) adds modest headwind to growth/chip stocks, but the weight of evidence leans toward a partial mean-reversion rather than continued downside.

• TSLAskipv1

  The -4.11% decline lacks a clear negative catalyst in recent headlines; in fact, news of Musk joining Trump for the Xi Summit could be modestly constructive for sentiment, suggesting the drop may be partially driven by broader market rotation or profit-taking rather than a fundamental shift. With 255 minutes remaining there is ample time for a partial recovery, especially if the Xi Summit headline gains traction intraday. The elevated 5-year inflation breakeven (2.62, ~1.9σ above trend) creates a risk-off macro backdrop that could cap any rebound, keeping the outlook uncertain rather than decisively bearish.

2 trigger(s), 0 bought, 2 skipped, 0 analyze failures, 2 watch-listed. Exits: 0.

• XOMskip-15.2% off 30d highp=0.38v1

  ExxonMobil's Q1 2026 fundamentals remain solid — $7.7B net income, $13B operating cash flow, and $1.76 EPS — showing no fundamental deterioration justifying a 15% drawdown. The drop appears macro-driven: broad recession fears, oil price pressure, and general risk-off sentiment (IWM -2.37%, SPY -0.95%) rather than any company-specific impairment. However, the 15% decline occurred against a backdrop of genuine macro headwinds including recession speculation, OPEC supply dynamics, and elevated 5-year inflation expectations (T5YIE 1.9σ above trend), suggesting the drawdown may persist until macro clarity improves — a recovery to $176 within 90 days would require roughly 18% appreciation, which is a high bar given current conditions.

• NFLXskip-21.6% off 30d highp=0.38v1

  Netflix's Q1 2026 financials are genuinely strong — $10.5B in revenue, $2.9B net income, $0.66 EPS, and $9B in cash — indicating no fundamental deterioration. However, the 21.6% drop from the 30-day high appears to carry meaningful idiosyncratic stress beyond today's broad market weakness (QQQ -1.83%, IWM -2.37%): the Texas lawsuit alleging data collection on children and addicting users introduces real regulatory/legal tail risk that is not yet quantified. The macro environment (elevated 5-year inflation breakevens at 1.9σ above trend) further pressures growth-multiple names, and the current price of $85.43 is strikingly low relative to recent financials, suggesting either heavy institutional selling or a sentiment-driven overshoot that may persist.

0 exits, no candidates in trigger band.

• portfoliolog

  No universe names in the 2-5% intraday move band.

7 pressure candidate(s), 0 opened, 7 skipped. Exits: 0.

2 trigger(s), 0 bought, 2 skipped, 0 analyze failures, 2 watch-listed. Exits: 0.

• NFLXskip-21.6% off 30d highp=0.38v1

  Netflix's Q1 2026 10-Q shows strong fundamentals — $10.5B revenue, $2.89B net income, $2.79B operating cash flow, and $9B in cash — suggesting no fundamental deterioration. However, at $85.43 the stock appears anomalously cheap relative to these metrics, raising questions about whether this price is realistic for this ticker in this timeframe; the 21.6% drop from a $108.95 30-day high is steep and the Texas lawsuit over data collection/child privacy adds genuine idiosyncratic legal risk on top of a broadly risk-off market day (QQQ -1.83%, IWM -2.37%). The combination of macro headwinds (elevated inflation expectations at 1.9σ above trend), a negative broad-market tape, and a fresh state AG lawsuit creating regulatory overhang makes a 90-day reversion to the prior high uncertain enough to fall below the conviction threshold.

• XOMskip-15.2% off 30d highp=0.38v1

  ExxonMobil remains financially sound with Q1 2026 EPS of $1.76, $83B in revenue, $12.95B in operating cash flow, and $10.7B in cash — no signs of fundamental deterioration. However, the 15.2% drop from the 30-day high appears largely macro-driven: recession fears, tariff/trade uncertainty, and broader energy sector headwinds are weighing on the stock, and with SPY already down ~0.95% today and oil macro sentiment mixed, a near-term catalyst for a full recovery to $176 within 90 days is not clearly in evidence. USO is up 4% today which provides some support, but the 5-year breakeven inflation print at 1.9σ above trend introduces rate/policy uncertainty that could suppress multiple expansion for energy equities.

2 exits, no candidates in trigger band.

• portfoliolog

  No universe names in the 2-5% intraday move band.

7 pressure candidate(s), 0 opened, 7 skipped. Exits: 0.

2 trigger(s), 0 bought, 2 skipped, 0 analyze failures, 2 watch-listed. Exits: 0.

• NFLXskip-21.6% off 30d highp=0.34v2

  Netflix's fundamentals remain solid — Q1 2026 10-Q shows strong EPS of $0.66, $10.5B in revenue, nearly $2.9B in net income, and $9B in cash, indicating no fundamental deterioration. However, the 21.6% drop from the 30-day high appears to reflect a combination of idiosyncratic headwinds (Texas lawsuit over data/privacy practices, rising ad-free pricing friction, broader streaming cost scrutiny) layered onto a risk-off macro environment with QQQ down 1.83% and elevated inflation expectations (T5YIE 1.9σ above trend). The dual pressure of a legal overhang and sector-wide sentiment drag makes a clean 90-day rebound to ~$109 a low-probability outcome despite the company's financial health.

• XOMskip-15.2% off 30d highp=0.41v2

  ExxonMobil's Q1 2026 10-Q shows solid fundamentals: $7.7B net income, $12.95B operating cash flow, and $1.76 EPS, indicating no fundamental deterioration. The 15.2% drop from the 30-day high appears primarily macro/sector-driven — oil price pressure and recession fears — rather than company-specific deterioration, and USO is actually up 4.06% today suggesting some oil price stabilization. However, the broader market is in risk-off mode (SPY -0.95%, IWM -2.37%), and elevated 5-year inflation expectations (T5YIE at 1.9σ above trend) combined with OPEC supply dynamics and Venezuela re-entry headlines create a complex macro backdrop that could keep energy stocks under pressure for the full 90-day window.

2 trigger(s), 0 bought, 2 skipped, 0 analyze failures, 2 watch-listed. Exits: 0.

• XOMskip-15.2% off 30d highp=0.41v2

  ExxonMobil's Q1 2026 financials remain robust — $83.1B in revenue, $7.7B net income, $13.0B operating cash flow, and a healthy cash position of $10.7B — indicating no fundamental deterioration. The 15.2% drop from the 30-day high appears largely macro-driven: broad energy sector pressure from oil price softness, recession concerns, and OPEC supply dynamics rather than company-specific distress. However, the recovery to the 30-day high of $176.41 requires a ~17.9% gain within 90 days, and while USO is up 4.06% today suggesting some oil price stabilization, persistent macro headwinds including recession fears, elevated 5-year inflation expectations (T5YIE at 1.9σ above trend adding uncertainty), and a weak broad market (SPY -0.95%, IWM -2.37%) make a full rebound within the 90-day window uncertain.

• NFLXskip-21.6% off 30d highp=0.34v2

  Netflix's Q1 2026 fundamentals remain strong — $10.5B revenue, $2.89B net income, and $9B in cash — suggesting the drop is not earnings-driven. However, the 21.6% decline from the 30-day high appears largely idiosyncratic: a Texas lawsuit over data collection/child privacy adds real regulatory overhang, and the ad-free standard plan repricing signals a maturing, price-sensitive subscriber base. The broad market is weak today (QQQ -1.83%, IWM -2.37%), but a 21.6% drawdown relative to those moves implies meaningful company-specific stress beyond macro contagion, reducing confidence in a clean mean-reversion trade within 90 days.

2 trigger(s), 0 bought, 2 skipped, 0 analyze failures, 2 watch-listed. Exits: 0.

• NFLXskip-21.6% off 30d highp=0.41v1

  Netflix's most recent 10-Q shows strong fundamentals: $10.5B in quarterly revenue, $2.89B net income, and $9.0B in cash, indicating no financial deterioration. The 21.6% pullback appears driven by macro noise (elevated inflation expectations at 1.9σ above trend), a Texas lawsuit over data collection (a legal risk but not an existential business threat), and possible sector rotation rather than any earnings miss or guidance cut. However, at $85.43 the stock has fallen sharply and the Texas litigation, rising streaming cost scrutiny, and macro headwinds introduce meaningful uncertainty about a full recovery to $108.95 within 90 days.

• XOMskip-15.2% off 30d highp=0.38v1

  XOM's Q1 2026 financials remain solid — $83.1B revenue, $7.7B net income, $12.95B operating cash flow, and $1.76 EPS — showing no fundamental deterioration. The 15.2% pullback from the 30-day high appears driven by macro headwinds (recession fears, trade uncertainty) and oil price softness rather than company-specific issues, and the upcoming ex-dividend date provides near-term support. However, elevated 5-year inflation breakevens (T5YIE at 1.9σ above trend) create a mixed macro signal — supportive for energy via inflation but offset by demand destruction risk if recession materializes.

Ratio 55.73, in-band. Holding GLD.

• portfoliohold

  Ratio 55.73 is inside [50, 80]; holding GLD.